Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: HUIYU PHARMACEUTICAL(688553) the Revenue is 282.65 M (+32.04%);the EBIT is 22.76 M (+158.5%);the EPS is 0.0564 (+164%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.28B32.04%
----
----
EBIT
0.02B158.52%
----
----
EPS
0.0564163.97%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf